Daniel K. Spiegelman - Jun 3, 2024 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role
Director
Signature
By: Justin Hunter For: Daniel K. Spiegelman
Stock symbol
MYGN
Transactions as of
Jun 3, 2024
Transactions value $
-$167,013
Form type
4
Date filed
6/4/2024, 05:57 PM
Previous filing
May 24, 2024
Next filing
Jun 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYGN Common Stock Sale -$83.5K -3.79K -9.35% $22.04 36.7K Jun 3, 2024 Direct F1
transaction MYGN Common Stock Sale -$83.5K -3.79K -10.32% $22.05 32.9K Jun 4, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.